Table 2:
Clinical characteristics of patients who experienced COVID-19 rebound (N=16)
| Variable | N (%) or Median (IQR) |
|---|---|
| Days from NM/r therapy initiation to COVID-19 rebound | 11 (9,13) |
| Symptoms (during COVID-19 rebound) | |
| Nasal Congestion/Runny Nose | 11 (68.8) |
| Cough | 10 (62.5) |
| Sore Throat | 4 (25.0) |
| Headache | 4 (25.0) |
| Fever/Chills | 3 (18.8) |
| Body Aches | 3 (18.8) |
| Fatigue | 3 (18.8) |
| Nausea/Vomiting/Diarrhea | 2 (12.5) |
| Shortness of Breath | 2 (12.5) |
| Abnormal Taste or Smell | 1 (6.3) |
| Healthcare System Encounters (during COVID-19 rebound) | |
| Hospital Admission | 1 (6.3) |
| Immediate Care Center | 4 (25) |
| Ambulatory/Outpatient | 4 (25) |
| Emergency Department | 1 (6.3) |
| Telemedicine | 6 (37.5) |